MedTrace Logo

The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Stroke

NCT04821518 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2021-03-29

No results posted yet for this study

Summary

The aim of the present study was to quantitatively assess the risk factors that may affect the re-occurrence of a CVD event and the use of a commercially available mobile application Samsung Health for the assessment of parameters of exercise tolerance and the ECG M-Trace Base II application for the assessment of cardiological parameters.

Conditions

  • Mobile Applications
  • Secondary Prevention
  • Stroke

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Ewa Chlebuś · Clinic Rehabilitation, University of Medical Sciences in Poznań

Eligibility

Min Age
42 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04821518 on ClinicalTrials.gov